Asia Press Agency

Tag: Research

  • Kerala Government to Establish Graphene Production Facility

    Kerala Government to Establish Graphene Production Facility

    The Kerala government, under the leadership of Chief Minister Pinarayi Vijayan, is embarking on a pioneering journey to establish a cutting-edge graphene production facility in the state. This ambitious project, valued at ₹237 crore, is set to harness the extraordinary electrical and electronic properties of graphene, often referred to as a “wonder material.”

     

    Graphene, recognized as the thinnest and strongest material globally, is celebrated for its exceptional attributes, including unparalleled electrical conductivity, chemical stability, transparency, and a substantial surface area. These characteristics make it a material of immense interest for a wide range of applications, from electronics to advanced materials.

     

    The state government’s decision to set up the graphene production facility was made during a cabinet meeting presided over by Chief Minister Pinarayi Vijayan. The project will operate under a public-private partnership model, fostering innovation and development while optimizing resource allocation. The total cost of this initiative is estimated at ₹237 crore, with the Kerala Digital University leading the implementation efforts.

     

    The Kerala Digital University will spearhead this project and has been authorized to prepare an initial proposal to secure loans from the Kerala Infrastructure Investment Fund Board (KIIFB). Moreover, the university will initiate a global expression of interest to identify private partners willing to contribute to this groundbreaking venture.

     

    KINFRA (Kerala Industrial Infrastructure Development Corporation) will play a pivotal role in infrastructure development for the graphene production facility. As a designated special purpose vehicle, KINFRA will leverage its expertise to ensure the smooth execution of the project.

     

    The government’s vision for a graphene ecosystem, as outlined in the 2022-23 budget, aims to stimulate advancements in material technologies. This ecosystem envisions a robust research and development framework, including the India Innovation Centre for Graphene. Although still in its initial stages, this research and development center will focus on the technological advancements enabled by graphene-based materials.

     

    In preparation for this forward-looking initiative, a managing committee will be formed, bringing together representatives from the Industries and IT Departments, as well as KINFRA. Their collective efforts will guide the development of the graphene production facility, ensuring that it aligns with the state’s goals and objectives.

     

    Additionally, the Chief Minister’s Office (CMO) shared that a middle-level graphene production unit is in the process of being established. This unit will serve as a pivotal step in realizing the potential of graphene, transforming it from a scientific curiosity into an industrially viable material with numerous applications.

     

    In other significant decisions, the cabinet has allocated an additional government guarantee of ₹100 crore to the Kerala State Backward Classes Development Corporation. This funding will support the extensive implementation of schemes under the National Safai Karmacharis Finance and Development Corporation, reflecting the government’s commitment to inclusive development and welfare.

     

    Kerala’s investment in graphene production underscores its commitment to fostering innovation and economic growth. By harnessing the remarkable properties of graphene, the state is positioning itself at the forefront of cutting-edge technology and materials, promising a brighter future for industries and research.

  • New Study Provides Clues to Understanding Long COVID

    New Study Provides Clues to Understanding Long COVID

    The quest to unravel the mysteries of long COVID is yielding promising clues, thanks to a new study conducted by researchers from the Icahn School of Medicine at Mount Sinai and Yale School of Medicine. Published in Nature, the study identifies crucial differences in certain biomarkers among individuals suffering from long COVID. While this research is a significant step forward, finding a definitive cure for the condition remains a complex challenge.

     

    In the United States, a substantial number of people continue to grapple with lingering symptoms associated with COVID. Recent reports from the Centers for Disease Control and Prevention (CDC) reveal that in 2022, approximately 18 million adults reported experiencing COVID, with around 8.8 million currently affected by it. Among children, about 1 million have been impacted, with approximately 360,000 still battling ongoing cases.

     

    The symptoms of long COVID vary widely among individuals, encompassing issues such as brain fog, extreme fatigue, shortness of breath, and a rapid pulse. The susceptibility to long COVID is influenced by a multitude of factors, including medical history, previous vaccinations, prior infections, and genetic factors.

     

    Long COVID is a complex condition that defies simple explanations, and currently, medical professionals must rely on symptom observation rather than concrete biomarkers for diagnosis.

     

    David Putrino, associated with Mount Sinai Health System, acknowledges the challenge of seeking a single biomarker or treatment for long COVID. Instead, researchers aim to develop a comprehensive toolkit to assist physicians in diagnosing and treating the condition effectively.

     

    The recent study conducted a detailed comparison between individuals with long COVID and those who are healthy (comprising those who never had COVID and those who recovered from it). Notably, the study excluded individuals who had been hospitalized with COVID to ensure that any lingering symptoms were not attributed to explainable factors such as lung damage from intubation.

     

    Among the notable findings, the study revealed that many individuals with long COVID exhibited significantly lower levels of cortisol, a hormone that regulates alertness. This hormonal imbalance could explain the extreme fatigue experienced by some long COVID sufferers. Researchers are now working to uncover the underlying causes of this hormone imbalance, which could ultimately lead to treatment strategies.

     

    The study also highlighted differences in immune responses among individuals with long COVID, including signs of B-cell activation and T-cell exhaustion. These findings suggest that the immune system remains in a state of prolonged activation, potentially due to the ongoing presence of the virus. Clinical trials are underway to investigate whether extended courses of antiviral treatments, such as Pfizer’s Paxlovid, can help eliminate the lingering virus and alleviate symptoms.

     

    Another significant discovery was the reactivation of latent viruses, such as the Epstein Barr virus, in some individuals with long COVID. This phenomenon may be attributed to an exhausted immune system, which struggles to keep latent viruses in check.

     

    While these findings do not represent a straightforward diagnostic test for long COVID, they provide valuable insights for both patients and doctors. Physicians can conduct hormone panel tests to identify dysregulation and assess evidence of latent virus reactivation.

     

    David Putrino suggests that more data will emerge in the future, and this research approach could serve as a model for investigating other enigmatic long-haul conditions, including chronic fatigue syndrome (ME/CFS) and long-term Lyme disease.

     

    Moreover, this research offers concrete biological evidence supporting the existence, which can help individuals with the condition combat skepticism and reinforce the validity of their experiences. This progress is a crucial step forward for the millions of people whose lives have been disrupted by chronic long COVID symptoms, ultimately bringing us closer to finding effective treatments and, hopefully, a cure.

  • Study: Precarious Employment, Higher Risk of Premature Death

    Study: Precarious Employment, Higher Risk of Premature Death

    A recent study conducted by Sweden’s Karolinska Institutet has shed light on the life-threatening consequences of precarious work conditions. Published in The Journal of Epidemiology and Community Reports, the research establishes a direct correlation between precarious employment and a significantly increased risk of premature death.

     

    Understanding Precarious Employment

    The term ‘precarious employment’ is used to describe job roles characterized by short-term contracts, temporary positions, low wages, and limited job security and benefits. Such conditions create an unstable and insecure work environment for employees.

     

    The paper’s author, Theo Bodin, stated, “The risk of early death is higher if one keeps working in jobs without a secure employment contract.”

     

    The Impact of Job Security

    What makes this study particularly noteworthy is its focus on the positive effects of secure employment. The research analyzed data from over 250,000 Swedish workers aged 20 to 55, collected between 2005 and 2017.

     

    The findings revealed that individuals who transitioned from precarious employment to stable, secure positions experienced a remarkable 20% reduction in the risk of premature death. This statistic underscores the crucial role that job security plays in promoting overall health and longevity.

     

    Call for Systemic Change

    Dr. Nuria Matilla-Santander, one of the study’s authors, stressed that reducing precariousness in the labor market could be a significant step in preventing premature deaths. The next phase of the research aims to delve deeper into the specific causes of mortality associated with precarious employment.

     

    “We can be relatively certain that the difference in mortality is due to the precariousness of employment rather than individual factors,” she noted.

     

    The study conducted by the Karolinska Institutet represents a significant contribution to understanding the public health implications of employment conditions. It underscores the urgent need for improving employment security as a preventive measure against premature death. Addressing the issue of precarious employment could lead to substantial improvements in overall well-being and life expectancy.